Academic · Private company
Dana-Farber Cancer Institute
Track this companyFree. Adds Dana-Farber Cancer Institute to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Daraxonrasib in Resectable PDACPHASE1 · NOT_YET_RECRUITING · started Apr 13, 2027ClinicalTrials.gov NCT07898813 · fetched Nov 12, 2026
- Development and Testing of Nutritional Algorithms (NACHO)NA · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT05825469 · fetched Nov 12, 2026
- my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young AdultsNA · NOT_YET_RECRUITING · started Nov 20, 2026ClinicalTrials.gov NCT07516353 · fetched Nov 12, 2026
- Acupuncture and Exercise for EV-Pembro-Induced Peripheral NeuropathyNA · RECRUITING · started Sep 3, 2026ClinicalTrials.gov NCT07548476 · fetched Nov 12, 2026
- RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal CancerPHASE2 · RECRUITING · started Aug 10, 2026ClinicalTrials.gov NCT07735624 · fetched Nov 12, 2026
- SMARCA4/2 Inhibitor for POU2F3-Positive SCLCPHASE2 · RECRUITING · started Apr 28, 2026ClinicalTrials.gov NCT07551635 · fetched Nov 12, 2026
- HEME Home Transfusion ProgramNA · RECRUITING · started Sep 10, 2025ClinicalTrials.gov NCT06487247 · fetched Nov 12, 2026
- Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality StudyNA · RECRUITING · started Jul 23, 2025ClinicalTrials.gov NCT06623097 · fetched Nov 12, 2026
- A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland CancersPHASE2 · RECRUITING · started Feb 26, 2025ClinicalTrials.gov NCT06805617 · fetched Nov 12, 2026
- Dance Study for Post-surgical Pain in Breast Cancer SurvivorsNA · ACTIVE_NOT_RECRUITING · started Jan 22, 2025ClinicalTrials.gov NCT06758102 · fetched Nov 12, 2026
- Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSLPHASE1 · RECRUITING · started Oct 18, 2024ClinicalTrials.gov NCT06475235 · fetched Nov 12, 2026
- The COMPASSION StudyNA · RECRUITING · started Sep 1, 2024ClinicalTrials.gov NCT06507930 · fetched Nov 12, 2026
- Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial CarcinomaEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started Aug 28, 2024ClinicalTrials.gov NCT06318871 · fetched Nov 12, 2026
- Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)NA · ACTIVE_NOT_RECRUITING · started Mar 28, 2024ClinicalTrials.gov NCT06322888 · fetched Nov 12, 2026
- Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE TrialNA · RECRUITING · started Feb 1, 2024ClinicalTrials.gov NCT06026111 · fetched Nov 12, 2026
- High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility StudyNA · RECRUITING · started Dec 4, 2023ClinicalTrials.gov NCT05740839 · fetched Nov 12, 2026
- Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART TrialNA · ACTIVE_NOT_RECRUITING · started Apr 14, 2022ClinicalTrials.gov NCT05236062 · fetched Nov 12, 2026
- Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative CancersPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 14, 2020ClinicalTrials.gov NCT04416568 · fetched Nov 12, 2026
- Pembrolizumab, Ibrutinib and Rituximab in PCNSLPHASE1_PHASE2 · RECRUITING · started Aug 1, 2020ClinicalTrials.gov NCT04421560 · fetched Nov 12, 2026
- Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AMLPHASE1 · ACTIVE_NOT_RECRUITING · started Oct 17, 2018ClinicalTrials.gov NCT03709758 · fetched Nov 12, 2026
- Physical Activity, Proliferation and Immune Markers in Benign Breast TissueNA · ACTIVE_NOT_RECRUITING · started Sep 17, 2018ClinicalTrials.gov NCT03657628 · fetched Nov 12, 2026
- Osimertinib In EGFR Mutant Lung CancerPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 13, 2018ClinicalTrials.gov NCT03586453 · fetched Nov 12, 2026
- Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started May 9, 2017ClinicalTrials.gov NCT03122717 · fetched Nov 12, 2026
- A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLLPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 27, 2014ClinicalTrials.gov NCT02158091 · fetched Nov 12, 2026
- INHERIT EGFR - Studying Germline EGFR MutationsACTIVE_NOT_RECRUITING · started Dec 28, 2012ClinicalTrials.gov NCT01754025 · fetched Nov 12, 2026